Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Bartley

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Rehabilitation Literature|January 1, 1981
Alternative work patterns and rehabilitationB T McMahon, P A Bartley
Blood Cells, Molecules & Diseases|March 22, 2001
Identification and validation of candidate Myb target genesP A Bartley, J K Lutwyche, T J Gonda
International Journal of Laboratory Hematology|May 25, 2010
Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNAP A Bartley, D M Ross, S Latham, et al.
Leukemia|April 17, 2013
Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patientsD M Ross, M O'Hely, P A Bartley, et al.
Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Rehabilitation Literature|January 1, 1981
Alternative work patterns and rehabilitationB T McMahon, P A Bartley
Blood Cells, Molecules & Diseases|March 22, 2001
Identification and validation of candidate Myb target genesP A Bartley, J K Lutwyche, T J Gonda
International Journal of Laboratory Hematology|May 25, 2010
Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNAP A Bartley, D M Ross, S Latham, et al.
Leukemia|April 17, 2013
Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patientsD M Ross, M O'Hely, P A Bartley, et al.
Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.
Pageof 1